Top Tweets for #FearlessForScience
TG announced two publications which highlight our therapy for #RMS. The articles were published in Frontiers in Immunology and CNS Drugs. Learn More/Read Articles: https://t.co/CStboVfYWm #FearlessForScience $TGTX
TG has shared presentations today at #ACTRIMS25 highlighting data from the ULTIMATE I & II Ph 3 trials and the ENHANCE Ph 3b trial in #RMS. Details: https://t.co/BmBi7Jhq8c Visit our $TGTX Business Suite in the exhibit hall if attending! #FearlessForScience #ACTRIMSForum
TG shared two presentations yesterday at #ACTRIMS24 in West Palm Beach, Florida, highlighting data from the ULTIMATE I & II Ph 3 trials and the ENHANCE Ph 3b trial in #RMS. Check out the data here: https://t.co/MmURy5DYKv #FearlessForScience #ACTRIMSForum $TGTX
#CMSC2023 $TGTX presented data from the ULTIMATE I & II Ph3 trials in #MS in an oral presentation yesterday during the CMSC conference. Details: https://t.co/xYwYpKnQB7
Presentation: https://t.co/SvwvfB4wAr
@MSCARE #FearlessForScience
Abstracts are Live! #CMSC2023 Aurora, CO May 31 - June 3. $TGTX will have 1 oral presentation highlighting analyses from the ULTIMATE I & II Ph3 trials in #MS. Visit our Booth #525 - Abstract: https://t.co/9nvwscYX8K Details: https://t.co/7m4sZ7EJ14 @MSCARE #FearlessForScience
TG Therapeutics is at #AANAM Boston 2023! Check out our 3 presentations highlighting additional analyses from the ULTIMATE I & II Ph3 trials in #MS. If attending, please visit our $TGTX team at Booth No. 1158. Details: https://t.co/PXlnPS80kU #FearlessForScience
#AANAM kicks-off tomorrow in Boston, MA, April 22-27. $TGTX will present 3 posters highlighting analyses from the ULTIMATE I & II Ph3 trials in #MS. Please visit our Booth No. 1158 if attending. Details: https://t.co/xv0vHNfMMi #FearlessForScience
March is #MSAwarenessMonth and TG recognizes the nearly 1 million people living with #MS in the US and the over 2.3 million worldwide. $TGTX honors everyone impacted by #MultipleSclerosis daily. #MyMSMoment #FearlessForScience
Abstracts are now LIVE at #AANAM Boston 2023!
Check out the abstracts and learn more: https://t.co/xv0vHNfMMi
$TGTX will share three presentations highlighting additional analyses from the ULTIMATE I & II Phase 3 trials in #MS #FearlessForScience
Earlier this month our first patient was treated at OhioHealth in Columbus with our newly approved therapy! Thank you @DrJNicholas and the entire staff! Learn more about our recent approval: https://t.co/ooQwG6Du11 $TGTX #FearlessforScience
We presented 2 posters during #ACTRIMS23 highlighting data from the ULTIMATE I & II Phase 3 trials in #MS – Check out the data here: https://t.co/Cqf9Szag9k #FearlessForScience $TGTX
Attending #ACTRIMS23? Visit the $TGTX Business Suite-lobby level Marriott Marquis Marina Hotel & check out our presentations today @ 6:30pm & 7pm PST highlighting additional analyses from the ULTIMATE I & II Ph3 trials in #MS. Details: https://t.co/GbaIsIlqdL #FearlessForScience
Join us in welcoming renowned MS expert Edward Fox, MD, PhD, to the $TGTX team! Dr. Fox joins with 30+ years of experience and dedication and has been integral in our development programs. Welcome, Dr. Fox! #FearlessforScience
#ICYMI: Last Wednesday, 12/28/22, the @US_FDA approved our new therapy to treat patients with relapsing forms of multiple sclerosis! For more information: https://t.co/ooQwG6Du11 #RMS #MS #FearlessforScience $TGTX
#ICYMI: Join us this morning @ 8:30AM ET to hear additional information about the @US_FDA approval of our new $TGTX therapy for relapsing forms of multiple sclerosis! #RMS #MS #FearlessForScience Webcast: https://t.co/5RNBBuGxFN Dial in: 1-877-407-8029 (US) 1-201-689-8029 (Ex-US)
Join us tomorrow at 8:30AM ET to discuss our recent @US_FDA approval in patients with relapsing forms of multiple sclerosis! #RMS #MS #FearlessforScience $TGTX Webcast: https://t.co/5RNBBuFZQf Dial in: 1-877-407-8029 (US) 1-201-689-8029 (Ex-US) Learn More: https://t.co/xvcfCdE36x
#Breaking: @US_FDA has approved our new therapy for relapsing forms of multiple sclerosis! We want to thank the patients & families, clinical trial staff, investigators & the TG team for making this approval possible! PR: https://t.co/ooQwG6E1Qz #RMS #MS #FearlessforScience $TGTX
$TGTX Q3 2022 Financial Results have been released. Details: https://t.co/11TYyFmprt Join our #Earnings call this morning at 8:30am ET. Dial in: 1-877-407-8029 (US), 1-201-689-8029 (Ex-US) Title: TG Therapeutics – Webcast at: https://t.co/5RNBBuGxFN #FearlessForScience
On Thursday, November 10th, we will be hosting a Q3 2022 Earnings Call at 8:30AM ET. Dial in: 1-877-407-8029 (U.S.), 1-201-689-8029 (Ex-US) Title: TG Therapeutics - Webcast available at: https://t.co/5RNBBuoorF $TGTX #FearlessForScience #Earnings
Results from the ULTIMATE I & II Phase 3 trials evaluating ublituximab in patients with relapsing forms of #MultipleSclerosis (RMS) were published in The New England Journal of Medicine. Details and Key Data: https://t.co/FJzKQmfYHW #NEJM $TGTX #FearlessForScience
Last Seen Hashtags on Sotwe
saatchiart
Seen from United States
ภูเก็ต
Seen from Singapore
momson() +filter:native_video
Seen from Spain
m자
Seen from Korea
deadNFT
Seen from United States
คลิปหลุด
Seen from Thailand
RentAGirlfriend
Seen from Japan
ukbops
Seen from United Kingdom
นัดเยสเครือสหพัฒน์
Seen from Thailand
femboyhijab
Seen from Turkey
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.1M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.9M followers
Taylor Swift
@taylorswift13
81.8M followers
Lady Gaga
@ladygaga
73.3M followers
Virat Kohli
@imvkohli
70.3M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63.1M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61M followers
X
@x
60.8M followers